Endoscopic Assessment of Inflammatory Bowel Disease: Colonoscopy/Esophagogastroduodenoscopy

Gastroenterology Clinics of North America

Volumn 41, Issue 2, 2012, Pages 271-290

  Chan, Grace ^a   Fefferman, David S ^b,c   Farrell, Richard J ^a  

^a Stroke and Hypertension Unit   (Ireland)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Private Practice   (United States)

Author keywords

Assessment; Colonoscopy; Endoscopy; Esophagogastroduodenoscopy; Inflammatory bowel disease

Indexed keywords

5 ACETAMIDOSALICYLIC ACID; ALCOHOL; ANTIINFLAMMATORY AGENT; INFLIXIMAB; NONSTEROID ANTIINFLAMMATORY AGENT; POLIDOCANOL; STEROID; TRIAMCINOLONE;

ACUTE SELF LIMITED COLITIS; BALLOON DILATATION; BLEEDING; CANCER RISK; COLITIS; COLON BIOPSY; COLON OBSTRUCTION; COLON PERFORATION; COLON RESECTION; COLONOSCOPY; COLORECTAL CANCER; CROHN DISEASE; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; DISEASE SEVERITY; DOUBLE BALLOON ENTEROSCOPY; DRUG MEGADOSE; DYSPLASIA; ENDOSCOPIC ECHOGRAPHY; ENTERITIS; ESOPHAGOGASTRODUODENOSCOPY; FECES CULTURE; HUMAN; ILEITIS; ILEOCOLONOSCOPY; INFECTIOUS COLITIS; INTESTINE INFECTION; INTESTINE OBSTRUCTION; ISCHEMIC COLITIS; PROCTITIS; PROGNOSIS; RADIATION INJURY; REMISSION; REVIEW; SCORING SYSTEM; SMALL INTESTINE OBSTRUCTION; TOXIC MEGACOLON; TREATMENT RESPONSE; ULCERATIVE COLITIS;

COLONOSCOPY; DIAGNOSIS, DIFFERENTIAL; ENDOSCOPY, DIGESTIVE SYSTEM; ENDOSCOPY, GASTROINTESTINAL; HUMANS; INFLAMMATORY BOWEL DISEASES;

EID: 84859649741     PISSN: 08898553     EISSN: 15581942     Source Type: Journal    
DOI: 10.1016/j.gtc.2012.01.014     Document Type: Review

References (154)

1. American Society for Gastrointestinal Endoscopy guideline: endoscopy in the diagnosis and treatment of inflammatory bowel disease. Gastrointest Endosc 2006, 63:558-565.
2. Carbonnel F., Lavergne A., Lemann M., et al. Colonoscopy of acute colitis. A safe and reliable tool for assessment of severity. Dig Dis Sci 1994, 39:1550-1557.
3. Navaneethan U., Parasa S., Venkatesh P.G., et al. Prevalence and risk factors for colonic perforation during colonoscopy in hospitalized inflammatory bowel disease patients. J Crohns Colitis 2011, 5:189-195.
4. Raza SH, Sultan N, Sabir M, et al. Value of unprepared colonoscopy in the management of inflammatory bowel disease. Presented at the Irish Society Gastroenterology meeting. Galway, Ireland, June 2-3, 2011.
5. Bernstein C., Shanahan F., Anton P., et al. Patchiness of mucosal inflammation in treated ulcerative colitis: a prospective study. Gastrointest Endosc 1995, 42:232-237.
6. Bentley E., Jenkins D., Campbell F., et al. How could pathologists improve the initial diagnosis of colitis?. Evidence from an international workshop. J Clin Pathol 2002, 55(12):955-960.
7. Cornaggia M., Leutner M., Mescoli C., et al. Chronic idiopathic inflammatory bowel diseases: the histology report. Dig Liver Dis 2011, 43:S293-S303.
8. Potzi R., Walgram M., Lochs H., et al. Diagnostic significance of endoscopic biopsy in Crohn's disease. Endoscopy 1989, 21:60-62.
9. Ramzan N.N., Leighton J.A., Heigh R.I., et al. Clinical significance of granuloma in Crohn's disease. Inflamm Bowel Dis 2001, 8:168-173.
10. Matsumoto T., Kudo T., Yao T., et al. Magnifying NBI colonoscopic findings in ulcerative colitis. Stomach Intestine 2007, 42:877-881.
11. Kudo T., Matsumoto T., Esaki M., et al. Mucosal vascular pattern in ulcerative colitis: observations using narrow band imaging colonoscopy with special reference to histologic inflammation. Int J Colorectal Dis 2009, 24:495-501.
12. Chutkan R.K., Waye J.D. Endoscopy in inflammatory bowel disease. Inflammatory bowel disease 2000, 453-477. Williams and Wilkins, Baltimore (MD). J.B. Kirsner (Ed.).
13. Byeon J.-S., Yan S.-K., Myung S.-J., et al. Clinical course of distal ulcerative colitis in relation to appendiceal orifice inflammation status. Inflamm Bowel Dis 2005, 11:366-371.
14. Mutinga M.L., Odze R.D., Wang H.H., et al. The clinical significance of right-sided colonic inflammation in patients with left-sided chronic ulcerative colitis. Inflamm Bowel Dis 2004, 10(3):215-219.
15. Paski S.C., Wightman R., Robert M.E., et al. The importance of recognizing increased cecal inflammation in health and avoiding the misdiagnosis and non-specific colitis. Am J Gastroenterol 2007, 102:2294.
16. Fefferman D.S., Farrell R.J. Endoscopy in inflammatory bowel disease: indications, surveillance, and use in clinical practice. Clin Gastroenterol Hepatol 2005, 3:11-24.
17. Friedman S. Endoscopic evaluation of polypoid lesions in patients with inflammatory bowel disease. Tech Gastrointest Endosc 2004, 6:175-181.
18. Maldonado T.S., Firoozi B., Stone D., et al. Colocolonic intussusception of a giant pseudopolyp in a patient with ulcerative colitis: a case report and review of the literature. Inflamm Bowel Dis 2004, 10:41-44.
19. Fujimura Y., Kamoi R., Lida M. Pathogenesis of aphthoid ulcers in Crohn's disease: correlative findings by magnifying colonoscopy, microscopy, and immunohistochemistry. Gut 1996, 38:724-732.
20. Geboes K., Janssens J., Rutgeerts P., et al. Crohn's disease of the esophagus. J Clin Gastroenterol 1986, 8:31-37.
21. Nugent F.W., Roy M.A. Duodenal Crohn's disease: an analysis of 89 cases. Am J Gastroenterol 1989, 84:249-254.
22. Reynolds H.L., Stellate T.A. Crohn's disease of the foregut. Surg Clin North Am 2001, 81:117-135.
23. Rao K.V., Sterling M.J., Klein K.M. Isolated gastroduodenal Crohn's disease presenting with acute pancreatitis. Gastroenterol Hepatol 2008, 4(7):494-499.
24. Ohmiya N., Arakawa D., Nakamura M., et al. Small-bowel obstruction: diagnostic comparison between double-balloon endoscopy and fluoroscopic enteroclysis, and the outcome of enteroscopic treatment. Gastrointest Endosc 2009, 69:84-93.
25. Oshitani N., Yukawa T., Yamagami H., et al. Evaluation of deep small bowel involvement by double-balloon enteroscopy in Crohn's disease. Am J Gastroenterol 2006, 101:1484-1489.
26. Fukumoto A., Tanaka S., Shishido T. Comparison of detectability of small-bowel lesions between capsule endoscopy and double-balloon endoscopy for patients with suspected small-bowel disease. Gastrointest Endosc 2009, 69:857-865.
27. Matsui T., Yao T., Sakurai T., et al. Clinical features and pattern of indeterminate colitis: Crohn's disease with ulcerative colitis-like clinical presentation. J Gastroenterol 2003, 38:647-655.
28. Wagtmans M.J., Van Hogezand R.A., Verspaget H.W., et al. Crohn's disease of the upper gastrointestinal tract. Neth J Med 1997, 50:S2-S7.
29. Lee S.D., Cohen R. Endoscopy in inflammatory bowel disease. Gastroenterol Clin N Am 2002, 31:119-132.
30. Gad A. The diagnosis of gastroduodenal Crohn's disease by endoscopic biopsy. Scand J Gastroenterol Suppl 1989, 167:23-28.
31. Wright C.L., Riddell R.H. Histology of the stomach and duodenum in Crohn's disease. Am J Surg Pathol 1998, 22:383-390.
32. Prenzel F., Uhlig H.H. Frequency of indeterminate colitis in children and adults with IBD - a metaanalysis. J Crohns Colitis 2009, 3(4):277-281.
33. Zhou N., Chen W.X., Chen S.H., et al. Inflammatory bowel disease unclassified. J Zhejiang Univ Sci B 2011, 12:280-286.
34. Bardhan K.D., Simmonds N., Royston C., et al. A United Kingdom inflammatory bowel disease database: making the effort worthwhile. J Crohns Colitis 2010, 4:405-412.
35. Farmer M., Petras R.E., Hunt L.E., et al. The importance of diagnostic accuracy in colonic inflammatory bowel disease. Am J Gastroenterol 2000, 95:3184-3188.
36. Odze R. Diagnostic problems and advances in inflammatory bowel disease. Mod Pathol 2003, 16:347-358.
37. Murrell Z.A., Melmed G.Y., Ippoliti A., et al. A prospective evaluation of the long term outcome of ileal pouch-anal anastomosis in patients with inflammatory bowel disease-unclassified and indeterminate colitis. Dis Colon Rectum 2009, 52:872-878.
38. Lemberg D.A., Clarkson C.M., Bohane T.D., et al. Role of esophagogastroduodenoscopy in the initial assessment of children with inflammatory bowel disease. J Gastroenterol Hepatol 2005, 20:1696-1700.
39. Pera A., Bellando P., Caldera D., et al. Colonoscopy in inflammatory bowel disease. Diagnostic accuracy and proposal of an endoscopic score. Gastroenterology 1987, 92:181-185.
40. Haskell H., Andrews C.W., Reddy S.I., et al. Pathologic features and clinical significance of "backwash" ileitis in ulcerative colitis. Am J Surg Pathol 2005, 29:1472-1481.
41. Goldstein N., Dulai M. Contemporary morphologic definition of backwash ileitis in ulcerative colitis and features that distinguish it from Crohn's disease. Am J Clin Pathol 2006, 126:365-376.
42. Lew R.J., Ginsberg G.G. The role of endoscopic ultrasound in inflammatory bowel disease. Gastrointest Endosc Clin N Am 2002, 12:561-571.
43. Mesenas S., Vu C., Doig L., et al. Duodenal EUS to identify thickening of the extrahepatic biliary tree wall in primary sclerosing cholangitis. Gastrointest Endosc 2006, 63:403-408.
44. Tedesco F.J., Hardin R.D., Harper R.N., et al. Infectious colitis endoscopically simulating inflammatory bowel disease: a prospective evaluation. Gastrointest Endosc 1983, 29:195-197.
45. Schumacher G., Kollberg B., Sandstedt B., et al. A prospective study of first attacks of inflammatory bowel disease and non-relapsing colitis: microbiologic findings. Scand J Gastroenterol 1993, 28:1077-1085.
46. Farrell R.J., LaMont J.T. Microbial factors in inflammatory bowel disease. Gastroenterol Clin North Am 2002, 31:41-62.
47. Surawicz C.M. What's the best way to differentiate infectious colitis (acute self-limited colitis) from IBD?. Inflamm Bowel Dis 2008, 14:S157-S158.
48. Holdsworth C.D. Acute self limited colitis. Br Med J (Clin Res Ed) 1984, 289:270-271.
49. Gast P. Endorectal ultrasound in infectious colitis may predict development of chronic colitis. Endoscopy 1999, 31:265-268.
50. Ellrichmann M., Wietzke-Braun P., Wintermeyer L., et al. Endoscopic ultrasound of the sigmoid colon for the differentiation of Crohn's disease from unspecific infectious colitis and healthy controls - a prospective, blinded, comparative study. Gastroenterology 2011, 140:S-692.
51. Wietzke-Braun P., Ellrichman M., Wintermeyer L., et al. Quantification of the level of inflammation in patients with ulcerative colitis compared to unspecific infectious colitis and healthy controls by endoscopic ultrasound of the sigmoid colon - a prospective, blinded, comparative study. Gastroenterology 2011, 140:S-693.
52. Pulimood A.B., Peter S., Ramakrishna B.S., et al. Segmental colonoscopic biopsies in the differentiation of ileocolic tuberculosis from Crohn's disease. J Gastroenterol Hepatol 2005, 20:688-696.
53. Li X., Liu X., Zou Y., et al. Predictors of clinical and endoscopic findings in differentiating Crohn's disease from intestinal tuberculosis. Dig Dis Sci 2011, 56:188-196.
54. Makharia G.K., Srivastava S., Das P., et al. Clinical, endoscopic, and histological differentiations between Crohn's disease and intestinal tuberculosis. Am J Gastroenterol 2010, 105:642-651.
55. Lee Y.J., Yang S.-K., Byeon J.-S., et al. Analysis of colonoscopic findings in the differential diagnosis between intestinal tuberculosis and Crohn's disease. Endoscopy 2006, 38:592-597.
56. Kim K.M., Lee A., Choi K.Y., et al. Intestinal tuberculosis: clinicopathologic analysis and diagnosis by endoscopic biopsy. Am J Gastroenterol 1998, 93:606-609.
57. Pulimood A.B., Ramakrishna B.S., Kurian G. Endoscopic mucosal biopsies are useful in distinguishing granulomatous colitis due to Crohn's disease from tuberculosis. Gut 1999, 45:537-541.
58. Baudet J.S., Castro V., Redondo I. Recurrent ischemic colitis induced by colonoscopy bowel lavage. Am J Gastroenterol 2010, 105:700-701.
59. Koutrobakis I.E., Sfiridaki A., Theodoropoulou A., et al. Role of acquired and hereditary thrombotic risk factors in colon ischemia of ambulatory patients. Gastroenterology 2001, 121:561-565.
60. Maupin G.E., Rimar S.D., Villalba M. Ischemic colitis following abdominal aortic reconstruction for rupture aneurysm. A 10 year experience. Ann Surg 1989, 55:378-380.
61. Su C., Brandt L., Sigal S.H., et al. The immunohistochemical diagnosis of E. coli 0157:H7 colitis: possible association with colon ischemia. Am J Gastroenterol 1998, 93:1055-1059.
62. Linder J., Monkemuller K., Raijman I., et al. Cocaine-associated ischemic colitis. South Med J 2000, 93:909-913.
63. Lucas W., Schroy P.C. Reversible ischemic colitis in a high endurance athlete. Am J Gastroenterol 1998, 93:2231-2234.
64. Lozano-Maya M., Ponferrada-Diaz A., Gonzalez-Asanza C., et al. Usefulness of colonoscopy in ischaemic colitis. Rev Esp Enferm Dig 2010, 102:478-483.
65. Toursarkissian B., Thompson R.W. Ischemic colitis. Surg Clin North Am 1997, 77:461-470.
66. Brandt L.J., Feuerstadt P., Blaszka M.C. Anatomic patterns, patient characteristics, and clinical outcomes in ischemic colitis: a study of 313 cases supported by histology. Am J Gastroenterol 2010, 105:2245-2252.
67. Margolius D., Cataldo T.E. Nonsteroidal anti-inflammatory drug colopathy mimicking masses of the colon: a report of three cases and review of the literature. Am Surg 2010, 76:1282-1286.
68. Kurahara K., Matsumoto T., Lida M. Characteristics of nonsteroidal an-inflammatory drugs-induced colopathy. Nihon Rinsho 2011, 69:1098-1103.
69. Puspok A., Kiener H.-P., Oberhuber G. Clinical endoscopic, and histologic spectrum of nonsteroidal anti-inflammatory drug-induced lesions in the colon. Dis Colon Rectum 2000, 43:685-691.
70. Riddell R.H. Pathology of idiopathic inflammatory bowel disease. Inflammatory bowel disease 1995, 517-552. Williams & Wilkins, Baltimore (MD). J.B. Kirsner, R.G. Shorter (Eds.).
71. Stolte M., Karimi D., Vieth M., et al. Strictures, diaphragms, erosions or ulcerations of ischemic type in the colon should always prompt consideration of nonsteroidal anti-inflammatory drug induced lesions. World J Gastroenterol 2005, 11:5828-5833.
72. Nagar A.B. Isolated colonic ulcers: diagnosis and management. Curr Gastroenterol Rep 2007, 9:422-428.
73. Kennedy G.D., Heise C.P. Radiation proctitis and colitis. Clin Colon Rect Surg 2007, 20:64-72.
74. Hovdenak N., Fajardo L.F., Hauer-Jensen M. Acute radiation proctitis: a sequential clinicopathologic study during pelvic radiotherapy. Int J Radiat Oncol Biol Phys 2000, 48:1111-1117.
75. Reichelderfer M., Morrisey J.F. Colonoscopy in radiation colitis. Gastrointest Endosc 1980, 26:41-43.
76. Habouchi N.Y., Schofield P.F., Rowland P.L. The light and electron microscopic features of early and late phase radiation-induced proctitis. Am J Gastroenterol 1988, 83:1140-1144.
77. Denham J.W., O'Brien P.C., Dunstan R.H., et al. Is there more than one late radiation proctitis syndrome?. Radiother Oncol 1999, 51:43-53.
78. Regueiro M., Rodemann J., Kip K.E., et al. Physician assessment of ulcerative colitis correlates poorly with endoscopic disease activity. In-flamm Bowel Dis 2011, 17:1008-1014.
79. Osada T., Ohkusa T., Okayasu I., et al. Correlations among total colonoscopic findings, clinical symptoms, and laboratory markers in ulcerative colitis. J Gastroenterol Hepatol 2008, 23:S262-S267.
80. Kato J., Kuriyama M., Hiraoka S., et al. Is sigmoidoscopy sufficient for evaluating inflammatory status of ulcerative colitis patients?. J Gastroenterol Hepatol 2011, 26:683-687.
81. Meucci G., Vecchi M., Astegiano M., et al. The natural history of ulcerative proctitis: a multicenter, retrospective study. Gruppo di Studio per le Malattie Inflammatorie Intestinali (GSMII). Am J Gastroenterol 2000, 95:469-473.
82. Truelove S.C., Witts L.J. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J 1955, ii:1041-1048.
83. Baron J.H., Connell A.M., Lemmard-Jones J.E. Variation between observers in describing mucosal appearances in proctocolitis. Br Med J 1964, 1:89-92.
84. Powell-Tuck J., Day D.W., Buckell N.A., et al. Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis. Dig Dis Sci 1982, 27:533-537.
85. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised control trial. Br Med J 1989, 298:82-86.
86. Schroeder K.W., Tremaine W., Ilstrup D.M. Coasted oral 5-aminosalycylic acid therapy for mildly to moderately active ulcerative colitis. New Engl J Med 1987, 317:1625-1629.
87. Sutherland L.R., Martin F., Greer S., et al. 5-aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterol 1987, 92:1894-1898.
88. Kiesslich R., Fritsch J., Holtmann M., et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 2003, 124:880-888.
89. Modigliani R., Mary J.Y., Simon J.F., et al. Clinical, biological and endoscopic picture of attacks of Crohn's disease. Evolution of prednisolone. Groupe d'Etude Therapeutiques des Affections Inflammatoires Digestives. Gastroenterology 1990, 98:811-818.
90. Daperno M., D'Haens G., van Assche G., et al. Development and validation of a new and simple endoscopic activity score for Crohn's disease: the SES-CD. Gastrointest Endosc 2004, 60:505-512.
91. Rutgeerts P., Geboes K., Vantrappen G., et al. Predictability of the postoperative course of Crohn's disease. Gastroenterology 1990, 99:956-963.
92. Yanai H., Nguyen G.C., Yun L., et al. Practice of gastroenterologists in treating flaring inflammatory bowel disease patients with clostridium difficile: antibiotics alone or combined antibiotics/immunomodulators?. Inflamm Bowel Dis 2011, 17:1540-1546.
93. Wright R., Truelove S.R. Serial rectal biopsy in ulcerative colitis during the course of a controlled therapeutic trial of various diets. Am J Dig Dis 1966, 11:847-857.
94. Lichtenstein G.R., Ramsey D., Rubin D.T. Randomised clinical trial: delayed-release oral mesalazine 4.8g/day vs. 2.4g/day in endoscopic mucosal healing - ASCEND I and II combined analysis. Aliment Pharmacol Ther 2011, 33:672-678.
95. Kamm M.A., Lichtenstein G.R., Sandborn W.J., et al. Effect of extended MMX mesalamine therapy for acute, mild-to-moderate ulcerative colitis. Inflamm Bowel Dis 2009, 15:1-8.
96. Colombel J.F., Rutgeerts P., Reinisch W., et al. Mucosal healing in patients with ulcerative colitis associates with a reduced colectomy risk, high incidence of symptomatic remissions, and corticosteroid-free state. Gut 2010, 59(Suppl III):A411.
97. Baert F., Moortgat L., Van Assche G., et al. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease. Gastroenterology 2010, 138:463-468.
98. Bjorkesten C.-G.A., Nieminen U., Turunen U., et al. Endoscopic monitoring of infliximab therapy in Crohn's disease. Inflamm Bowel Dis 2010, 17:947-953.
99. Schnitzler F., Fidder H., Ferrante M., et al. Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease. Inflamm Bowel Dis 2009, 15:1295-1301.
100. Rutgeerts P., Feagan B.G., Lichtenstein G.R., et al. Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease. Gastroenterology 2004, 126:402-413.
101. Lutgens M.W., Oldenburg B., Siersema P.D., et al. Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease. Br J Cancer 2009, 101:1671-1675.
102. Rutter M., Saunders B., Wilkinson K., et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 2004, 126:451-459.
103. Itzkowitz S.H., Harpaz N. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Gastroenterol 2004, 126:1634-1648.
104. Eaden J., Abrams K.R., Mayberry J.F. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001, 48:526-535.
105. Sachar D.B. Cancer in Crohn's disease: dispelling the myths. Gut 1994, 35:1507-1508.
106. Gillen C.D., Anfrews H.A., Prior P., et al. Crohn's disease and colorectal cancer. Gut 1994, 35:651-655.
107. Bernstein C.N., Blanchard J.F., Kliewer E., et al. Cancer risk in patients with inflammatory bowel disease: a population based study. Cancer 2001, 91:854-862.
108. Rutter M.D., Saunders B.P., Wilkinson K.H., et al. Most dysplasia in ulcerative colitis is visible at colonoscopy. Gastrointest Endosc 2004, 60:334-339.
109. Rubin C., Haggitt R., Burner G. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology 1992, 103:1611-1620.
110. Eaden J.A., Ward B.A., Mayberry J.F. How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance. Gastrointest Endosc 2000, 51:123-128.
111. Gearry R.B., Wakeman C.J., Barclay M.L., et al. Surveillance for dysplasia in patients with inflammatory bowel disease: a national survey of colonoscopic practice in New Zealand. Dis Colon Rectum 2004, 47:314-322.
112. Rutter M.D. Surveillance programmes for neoplasia in colitis. J Gastroenterol 2011, 46:S1-S5.
113. Blackstone M.O., Riddell R.H., Rogers B.H., et al. Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. Gastroenterology 1981, 80:366-374.
114. Butt J.H., Konishi F., Morson B.C., et al. Macroscopic lesions in dysplasia and carcinoma complicating ulcerative colitis. Dig Dis Sci 1983, 28:18-26.
115. Schneider A., Stolte M. Differential diagnosis of adenomas and dysplastic lesions in patients with ulcerative colitis. Z Gastroenterol 1993, 31:653-656.
116. Cross S.S., Vergani P., Stephenson T., et al. Dysplasia-associated mass or lesion (DALM) and sporadic adenomas in patients with chronic idiopathic inflammatory bowel disease. Diagnostic Histopathology 2007, 14:110-115.
117. Odze R.D., Brown C.A., Hartmann C.J., et al. Genetic alterations in ulcerative colitis-associated adenoma-like DALMs are similar to non-colitic sporadic adenomas. Am J Surg Pathol 2000, 24:1209-1216.
118. Rubin P.H., Firedman S., Harpaz N., et al. Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps. Gastroenterology 1999, 117:1295-1300.
119. Ullman T.A., Wild D., Murphy S.J., et al. The natural history of dysplasia in inflammatory bowel disease: influence of disease type and dysplasia morphology and grade on cancer risk. Gastroenterology 2008, 134:A-346.
120. Lim C.H., Dixon M.F., Vail A., et al. Ten year follow up of ulcerative colitis patients with and without low grade dysplasia. Gut 2003, 52:1127-1132.
121. Connell W.R., Lennard-Jones J.E., Williams C.B., et al. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 1994, 107:934-944.
122. Itzkowitz S.H., Present D.H. Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis 2005, 11:314-321.
123. Chan E.P., Lichtenstein G.R. Endoscopic evaluation for cancer and dysplasia in patients with inflammatory bowel disease. Tech Gastrointest Endosc 2004, 6:169-174.
124. Matsumoto T., Kudo T., Jo Y., et al. Magnifying colonoscopy with narrow band imaging system for the diagnosis of dysplasia in ulcerative colitis: a pilot study. Gastrointest Endosc 2007, 66:957-965.
125. Dekker E., van den Broek F.J., Reitsma J.B., et al. Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitis. Endoscopy 2007, 39:216-221.
126. Goldberg H.I., Caruthers S.B., Nelson J.A., et al. Radiographic findings of the National Cooperative Crohn's Disease study. Gastroenterology 1979, 77:925-937.
127. Fukumoto A., Tanaka S., Yamamoto H., et al. Diagnosis and treatment of small-bowel stricture by double balloon endoscopy. Gastrointest Endosc 2007, 66:S108-S112.
128. Yamazaki Y., Ribeiro M.B., Sachar D.B., et al. Malignant colorectal strictures in Crohn's disease. Am J Gastroenterol 1991, 86:882-885.
129. Gumaste V., Sachar D.B., Greenstein A.J. Benign and malignant colorectal strictures in ulcerative colitis. Gut 1992, 33:938-941.
130. Menon A.M., Mirza A.H., Moolla S., et al. Adenocarcinoma of the small bowel arising from a previous strictureplasty for Crohn's disease: report of a case. Dis Colon Rectum 2006, 50:257-259.
131. Jaskowiak N.T., Michelassi F. Adenocarcinoma at a strictureplasty site in Crohn's disease: report of a case. Dis Colon Rectum 2001, 44:284-287.
132. Erkelens G.W., van Deventeer S.J.H. Endoscopic treatment of strictures in Crohn's disease. Best Pract Res Clin Gastroenterol 2004, 18:201-207.
133. Bernstein C.N. The role of an endoscopy in inflammatory bowel disease. Clinical Update 2008, 15:1-4.
134. Couckuyt H., Gevers A.M., Coremans G., et al. Efficacy and safety of hydrostatic balloon dilatation of ileocolonic Crohn's strictures: A prospective longterm analysis. Gut 1995, 36:577-580.
135. Wibmer A.G., Kroesen A.J., Grone J., et al. Comparison of strictureplasty and endoscopic balloon dilatation for structuring Crohn's disease-review of the literature. Int J Colorectal Dis 2010, 25:1149-1157.
136. Thienpont C., D'Hoore A., Vermeire S., et al. Long-term outcome of endoscopic dilatation in patients with Crohn's disease is not affected by disease activity or medical therapy. Gut 2010, 59:320-324.
137. Hassan C., Zullo A., De Francesco V., et al. Systematic review: endoscopic dilatation in Crohn's disease. Aliment Pharmacol Ther 2007, 26:1457-1464.
138. Grubel P., Choi Y., Schneider D., et al. Severe isolated Crohn's-like disease of the gastroduodenal tract. Dig Dis Sci 2003, 48:1360-1365.
139. Oka S., Tanaka S., Fukumoto A., et al. Endoscopic ultrasonography with double balloon enteroscopy for small bowel diseases. Tech Gastrointest Endosc 2008, 10:113-118.
140. Ramboer C., Verhamme M., Dhondt E., et al. Endoscopic treatment of stenosis in recurrent Crohn's disease with balloon dilation combined with local corticosteroid injection. Gastrointest Endosc 1993, 42:252-255.
141. Brooker J.C., Beckett C.G., Saunders B.P., et al. Long-acting steroid injection after endoscopic dilation of anastomotic Crohn's strictures may improve the outcome. A retrospective case series. Endoscopy 2003, 35:333-337.
142. Lavy A. Triamcinolone improves outcome in Crohn's disease strictures. Dis Colon Rectum 1997, 40:184-186.
143. Bloomberg B., Rolny P., Jarnerot G. Endoscopic treatment of anastomotic strictures in Crohn's disease. Endoscopy 1991, 23:195-198.
144. Matsuhashi N., Nakajima A., Suzuki A., et al. Nonsurgical strictureplasty for intestinal strictures in Crohn's disease: preliminary report of two cases. Gastrointest Endosc 1997, 45:176-178.
145. Matsuhashi N., Nakajima A., Suzuki A., et al. Long-term outcome of non-surgical strictureplasty using metallic stents for intestinal strictures in Crohn's disease. Gastrointest Endosc 2000, 51:343-345.
146. Greenstein A.J., Kark A.E., Dreiling D.A. Crohn's disease of the colon. II. Controversial aspects of hemorrhage, anaemia and rectal involvement in granulomatous disease involving the colon. Am J Gastroenterol 1975, 63:40-48.
147. Cirocco W.C., Reilly J.C., Rusin L.C. Life threatening hemorrhage and exsanguinations from Crohn's disease. Report of four cases. Dis Colon Rectum 1995, 38:85-95.
148. Kostka R., Lukas M. Massive, life threatening bleeding in Crohn's disease. Acta Chir Belg 2005, 105:168-174.
149. Robert J.H., Sachar D.B., Aufses A.H., et al. Management of severe hemorrhage in ulcerative colitis. Am J Surg 1990, 159:550-555.
150. Edwards F.C., Truelove S.C. The course and prognosis of ulcerative colitis. III. Complications. Gut 1964, 5:1-26.
151. Bruce D., Cole W.H. Complications of ulcerative colitis. Ann Surg 1962, 155:768-781.
152. Belaiche J., Louis E., D'Haens G., et al. Acute lower gastrointestinal bleeding in Crohn's disease: characteristics of a unique series of 34 patients. Belgian IBD research Group. Am J Gastroenterol 1999, 94:2177-2181.
153. Hirana H., Atsumi M., Sawai N., et al. A case of ulcerative colitis with local bleeding treated by endoscopic injection of absolute ethanol and 1% polidocanol. Gastroenterol Endosc 1999, 4:969-973.
154. Yoshida Y., Kawaguchi A., Mataki N., et al. Endoscopic treatment of massive lower GI hemorrhage in two patients with ulcerative colitis. Gastrointest Endosc 2001, 54:779-781.